BIOSTIME INTL

BE:8BI Germany Other
Market Cap
$13.87K
€13.51K EUR
Market Cap Rank
#44401 Global
#7276 in Germany
Share Price
€1.41
Change (1 day)
+2.17%
52-Week Range
€0.84 - €1.59
All Time High
€1.59
About

BIOSTIME INTL operates in Diversified Metals & Mining.

BIOSTIME INTL (8BI) - Total Liabilities

Latest total liabilities as of December 2023: €13.75 Billion EUR

Based on the latest financial reports, BIOSTIME INTL (8BI) has total liabilities worth €13.75 Billion EUR as of December 2023.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

BIOSTIME INTL - Total Liabilities Trend (2016–2023)

This chart illustrates how BIOSTIME INTL's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

BIOSTIME INTL Competitors by Total Liabilities

The table below lists competitors of BIOSTIME INTL ranked by their total liabilities.

Company Country Total Liabilities
Advanced Biomedical Technologies Inc
PINK:ABMT
USA $8.70 Million
GreenBank Capital Inc
PINK:GRNBF
USA $6.53 Million
Devolver Digital Inc
LSE:DEVO
UK GBX30.74 Million
Golden Developing Solutions Inc
PINK:DVLP
USA $9.20 Million

Liability Composition Analysis (2016–2023)

This chart breaks down BIOSTIME INTL's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.61 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 2.18 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.69 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how BIOSTIME INTL's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for BIOSTIME INTL (2016–2023)

The table below shows the annual total liabilities of BIOSTIME INTL from 2016 to 2023.

Year Total Liabilities Change
2023-12-31 €13.75 Billion -7.25%
2022-12-31 €14.82 Billion +2.95%
2021-12-31 €14.40 Billion +30.69%
2020-12-31 €11.02 Billion +7.29%
2019-12-31 €10.27 Billion +2.62%
2018-12-31 €10.01 Billion +0.88%
2017-12-31 €9.92 Billion -9.91%
2016-12-31 €11.01 Billion --